Aurora Cannabis Inc.

Aurora Cannabis Inc.

Price: 3.29

Company and Business Model

Aurora Cannabis Inc. operates in the healthcare sector, focusing on the production and distribution of cannabis products for medical and recreational use. Its core offerings include dried flower, oils, and edibles, catering to both consumers and healthcare providers. The company generates revenue primarily through the sale of these cannabis products, with significant operations in North America. Aurora also engages in research and development to enhance its product portfolio and market reach.

Investment Profile

The investment profile of Aurora Cannabis Inc. is more aligned with growth investors, given its focus on expanding market presence and product innovation. The company currently does not offer dividends, which may not appeal to income-focused investors. Its performance metrics indicate a higher risk profile, suggesting that potential investors should be prepared for volatility.

Official website

Fundamental metrics (experimental)

EPS (TTM) — earnings per share for the last 12 months, $
-1.69 Risk
Revenue QoQ — quarter-over-quarter revenue growth
4.2%
EPS surprise
-7.4% worse than expected
20d volatility
2.5% stable
FMP / FinFeed data updated: 2026-06-06
Reco: Sell Potential: 30 Risk: 80 Updated: 2026-06-11 05:29
How recommendation works
Why AI thinks so:
Weak fundamentals and negative momentum raise significant concerns.

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell
AI recommendation changes
Date Before After Reason
2026-06-09 02:56 Hold Sell Weak fundamentals and negative momentum raise significant risk.
2026-06-01 02:55 Sell Hold Weak fundamentals and negative momentum raise concerns.
2026-05-24 02:30 Hold Sell Weak fundamentals and negative momentum raise significant risk.
Aurora Cannabis Inc. Canopy Growth Corporation

Что переопределение Трампа марихуаны и CBD может значить для пожилых людей, исследований и акций

Недавние изменения, предложенные Дональдом Трампом, касаются переклассификации марихуаны и CBD, что может оказать значительное влияние на пожилых людей, их здоровье и финансовые рынки.